High Court In India Imposes Stay In Aventis Pharma/Novartis Dispute
This article was originally published in PharmAsia News
Executive Summary
India's Bombay High Court halted distribution of Aventis Pharma's Verorab vaccine against rabies, which competes with a Novartis vaccine